Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

RegeneCure Ltd.

http://www.regenecure.co.il

Latest From RegeneCure Ltd.

Start-Up Quarterly Statistics, Q1 2011

Biopharma and medical device start-ups brought in a total of $216 million in Q1 2011. Absent were any financings involving in vitro diagnostics companies. Only four acquisitions involving start-ups were completed - one in biopharma and three in the device industry. Cancer was the most popular therapeutic category among biopharma start-up alliance this quarter.

BioPharmaceutical Medical Device

Recent Tech Transfer Deals (04/11)

Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.

Selected Start-Ups (03/2011)

In Vivo briefly describes these recently founded companies: 2C Tech Corp., Atherolysis Medical, Axena Technologies, Diartis Pharmaceuticals, Prevention Pharmaceuticals and RegeneCure.

See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
UsernamePublicRestriction

Register